“Matching-Adjusted Indirect Comparison (MAIC) of Deucravacitinib Versus Adalimumab for the Treatment of Patients With Moderate to Severe Plaque Psoriasis over 2 Years”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s112, https://doi.org/10.25251/skin.7.supp.112.